International Flavors & Fragrances (IFF) is a global leader in the creation and distribution of flavors, fragrances, and specialty ingredients, operating across diverse industries through its Nourish, Health & Biosciences, Scent, and Pharma Solutions segments. As a key player in the specialty chemicals sector, IFF leverages its extensive portfolio to deliver innovative solutions that enhance product sensory experiences worldwide. In its most recent reported quarters, IFF demonstrated a mixed performance. For Q2 2025, the company reported EPS of $1.15 against an estimate of $1.12, and revenue of $2.764 billion. This followed a Q1 2025 where EPS was $1.20, exceeding the estimate of $1.14, with revenue at $2.843 billion. Comparing these to the prior two quarters, Q4 2024 saw EPS of $0.97 against an estimate of $0.82, and Q3 2025 had EPS of $1.05 against an estimate of $1.02. This indicates a recent trend of EPS beats, with revenue figures available for Q4 2024 and Q1/Q2 2025 showing some fluctuation. Historically, IFF has shown a pattern of beating analyst estimates for EPS in recent quarters, including Q4 2024, Q1 2025, Q2 2025, and Q3 2025, though revenue data is less consistently available for direct comparison over longer periods. Recent news indicates analyst adjustments to price targets, with UBS lowering its target to $75 from $85 while maintaining a Neutral rating, and BNP Paribas reducing its target to $85 from $88 with an "Outperform" rating. These adjustments suggest a more cautious near-term outlook from some analysts despite overall positive sentiment. Investors will be watching for continued EPS beats and a clearer revenue growth trajectory in upcoming reports, particularly as the company navigates market expectations following these analyst revisions. Key will be management's commentary on segment performance and any indications of accelerating growth drivers.
